Navigation Links
Cervical Cancer Vaccine Show Promise In Prevention

We might soon have a vaccine to combat a disease (cervical cancer) that has been haunting the world. The pharmaceutical giant Merck had submitted details of a cervical cancer vaccine, // shown to offer protection against 70% of the known types of infection with the human papilloma virus (HPV) to the U.S. Food and Drug Administration (FDA).

Another vaccine, developed by GlaxoSmithKline wound soon be approved for use in Europe and other countries excluding the U.S. The vaccine is believed to be highly effective in preventing cervical cancer. The launch of the vaccine would be associated with few controversies regarding usage, age of administration and indications for the vaccination.

It is hoped that immunization of pre-teen girls would be made mandatory, as the vaccine has been shown to be effective in the induction of immunity, in this specific population. Issues related to promotion of premarital sex as a consequence of vaccination are yet to be resolved. Researchers feel that any therapy that has the potential to prevent cancer should be approved for use, surpassing emotional concerns.

The success of this programme, however, largely depends on sustained efforts. The vaccine is yet to be approved for use in countries, where a poor acknowledgement and acceptance of extramarital sex and premarital sex is still prevalent. The effect of the vaccine on males is yet to be analyzed.

Infection with human papilloma virus is a major risk factor in the development of cervical cancer. In fact, it accounts for 70% of all cervical cancers. Many different viral strains of the HPV exist. The most significant strain related to cervical cancer is subtypes HPV-16 and HPV-18, both of which can be counteracted by the vaccine. The Merck formulation can combat HPV-6 and HPV-11 subtypes.

More than 4,000 women die in the United States every year, due to cervical cancer. The mortality is much higher in countries where access to health care facilities (Pap smear) is very poor. This teat has the potential to detect pre-cancerous lesions that can turn cancerous sometime later.

The development of a vaccine cannot be viewed as a substitute for the Pap smear test as it does not confer any protection against 30% of cervical cancers, caused by other types of HPV. It can however reduce the false positive Pap smear reports, and save the investment involved in subsequent biopsies and other follow-up tests.

The successful development of the cervical vaccine would not have been possible if not for the isolation of a HPV protein, found to result in an immune stimulation against the virus. This has led to the massive production of a safe and efficient cervical cancer vaccine.

Organizations such as the Family Research Council and the Medical Institute for Sexual Health have expressed interest in the launch of the vaccine following approval by the FDA. The process of approval would be monitored by such organizations. Adequate knowledge about the availability of the vaccine and its use has to be imparted to medical professionals following approval by the Centers for Disease Control and Prevention (CDC). Issues related to vaccination and seeking insurance also have to be further sorted before the vaccine can be marketed for commercial use.


'"/>




Related medicine news :

1. Virus Level could Predict Cervical Cancer Risk
2. Smallpox Vaccine May Help Fight Cervical Cancer
3. Obesity Increases Risk of Cervical Cancer
4. Reducing The Risk Of Cervical Cancer
5. Improving Fertility In Patients With Cervical Cancer
6. Vaccine for Cervical cancer
7. Cervical spinal injury patients may have more damage left undetected
8. Cervical Cancer Vaccine To Be Developed In India
9. Cervical Cancer Can Now Be Better Handled With Gene Silencing Therapy
10. Cervical Cancer Recurrence Risk Even After Removal Of Pre-Cancerous Cells
11. HPV Vaccines for Cervical Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice ... "Film editors can give their videos a whole new perspective by using the ... of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
Breaking Medicine Technology: